That doesn’t say that eating fat causes diabetes… it suggests that being fat causes diabetes.
Laura Saslow, associate professor at the University of Michigan School of Nursing, has been researching the impact of different dietary patterns on type 2 diabetes for more than a decade.
news.umich.edu
The Indiana University study showed a big drop in medication use among people on the keto diet. About 60% of those using insulin stopped needing it entirely. Medication use went down a lot in the keto group, unlike the control group where it stayed the same or went up. Overall, 47% of people on the keto diet achieved remission or reversal after one year and 38% after two years. In the control group, 7-10% of people achieved remission or reversal after 1-2 years.
When comparing the studies(keto and low calorie) the results were pretty much identical with regard to diabetes remission or reversal.
Objective Dietary carbohydrate is the major determinant of postprandial glucose levels, and several clinical studies have shown that low-carbohydrate diets improve glycemic control. In this study, we tested the hypothesis that a diet lower in carbohydrate would lead to greater improvement in...
nutritionandmetabolism.biomedcentral.com
Eighty-four community volunteers with obesity and type 2 diabetes were randomized to either a low-carbohydrate, ketogenic diet (<20 g of carbohydrate daily; LCKD) or a low-glycemic, reduced-calorie diet (500 kcal/day deficit from weight maintenance diet; LGID). Both groups received group meetings, nutritional supplementation, and an exercise recommendation. The main outcome was glycemic control, measured by hemoglobin A1c.
Results
Forty-nine (58.3%) participants completed the study. Both interventions led to improvements in hemoglobin A1c, fasting glucose, fasting insulin, and weight loss. The LCKD group had greater improvements in hemoglobin A1c (-1.5% vs. -0.5%, p = 0.03), body weight (-11.1 kg vs. -6.9 kg, p = 0.008), and high density lipoprotein cholesterol (+5.6 mg/dL vs. 0 mg/dL, p < 0.001) compared to the LGID group. Diabetes medications were reduced or eliminated in 95.2% of LCKD vs. 62% of LGID participants (p < 0.01).
To assess the pleiotropic effects of ketogenic diets (KD) on glucose control, changes in medication, and weight loss in individuals with type 2 diabetes, and to evaluate its practical feasibility KD results in improved HbA1c already after 3 weeks, ...
www.ncbi.nlm.nih.gov
A reduction in the use of glucose-lowering medications subsequent to KD has been observed by several studies. In a study by Saslow et al., 60% of participants could discontinue sulfonylureas and/or DPP-4 inhibitors, and 30% metformin after KD, but none of the subjects could do so in the control group [
25]. Tay et al. reported a greater reduction in glucose-lowering agents following KD compared to the control group (
p=0.02) [
29]. At the 1-year follow-up, Hallberg et al. documented a significant reduction for all diabetes medications in participants of the KD group compared with the usual intervention [
24]. Specifically, the overall prescriptions (not including metformin) dropped from 57 to 30%; insulin therapy was reduced/interrupted in 94% of users, sulfonylureas were discontinued in 100% of users, and metformin decreased slightly (from 71 to 65%,
p=0.04)